Find the pharmaceutical Marketplace for latest API enquiries of Gadolinium Dtpa on PharmaCompass.com

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

0 DRUGS IN DEVELOPMENT

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

1 RELATED EXCIPIENT COMPANIES

1EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Gadopentetic acid dimeglumine salt, 2-[bis[2-[carboxylatomethyl(carboxymethyl)amino]ethyl]amino]acetate;gadolinium(3+);(2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentol, Gadopentetic acid dimeglumine, Chebi:31797, Sh l 451a, Sh-l-451a
Molecular Formula
C28H54GdN5O20
Molecular Weight
938.0  g/mol
InChI Key
LGMLJQFQKXPRGA-VPVMAENOSA-K

Gadolinium Dtpa
A complex of gadolinium with a chelating agent, diethylenetriamine penta-acetic acid (DTPA see PENTETIC ACID), that is given to enhance the image in cranial and spinal MRIs. (From Martindale, The Extra Pharmacopoeia, 30th ed, p706)
1 2D Structure

Gadolinium Dtpa

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[bis[2-[carboxylatomethyl(carboxymethyl)amino]ethyl]amino]acetate;gadolinium(3+);(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
2.1.2 InChI
InChI=1S/C14H23N3O10.2C7H17NO5.Gd/c18-10(19)5-15(1-3-16(6-11(20)21)7-12(22)23)2-4-17(8-13(24)25)9-14(26)27;2*1-8-2-4(10)6(12)7(13)5(11)3-9;/h1-9H2,(H,18,19)(H,20,21)(H,22,23)(H,24,25)(H,26,27);2*4-13H,2-3H2,1H3;/q;;;+3/p-3/t;2*4-,5+,6+,7+;/m.00./s1
2.1.3 InChI Key
LGMLJQFQKXPRGA-VPVMAENOSA-K
2.1.4 Canonical SMILES
CNCC(C(C(C(CO)O)O)O)O.CNCC(C(C(C(CO)O)O)O)O.C(CN(CC(=O)O)CC(=O)[O-])N(CCN(CC(=O)O)CC(=O)[O-])CC(=O)[O-].[Gd+3]
2.1.5 Isomeric SMILES
CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.C(CN(CC(=O)O)CC(=O)[O-])N(CCN(CC(=O)O)CC(=O)[O-])CC(=O)[O-].[Gd+3]
2.2 Synonyms
2.2.1 MeSH Synonyms

1. Diethylenetriaminepenta-acetic Acid, Gadolinium

2. Dimeglumine, Gadolinium Dtpa

3. Dimeglumine, Gadopentetate

4. Dtpa, Gadolinium

5. Gadolinium Diethylenetriaminepenta Acetic Acid

6. Gadolinium Diethylenetriaminepenta-acetic Acid

7. Gadolinium Dtpa

8. Gadolinium Dtpa Dimeglumine

9. Gadolinium Dtpa Dimeglumine Salt

10. Gadolinium Dtpa Disodium Salt

11. Gadopentetate Dimeglumine

12. Gadopentetic Acid

13. Gd Dtpa

14. Gd-dtpa

15. Magnevist Enteral

16. Magnograf

17. Magnograf Enteral

2.2.2 Depositor-Supplied Synonyms

1. Gadopentetic Acid Dimeglumine Salt

2. 2-[bis[2-[carboxylatomethyl(carboxymethyl)amino]ethyl]amino]acetate;gadolinium(3+);(2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentol

3. Gadopentetic Acid Dimeglumine

4. Chebi:31797

5. Sh L 451a

6. Sh-l-451a

7. Dtxsid70235367

8. Akos015896299

9. Bay-86-4882

10. D01707

11. Q413793

12. Gadolinium (bis{2-[(carboxylatomethyl)(carboxymethyl)amino]ethyl}amino)acetate--1-deoxy-1-(methylamino)-d-glucitol (1:2)

2.3 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 938.0 g/mol
Molecular Formula C28H54GdN5O20
Hydrogen Bond Donor Count14
Hydrogen Bond Acceptor Count25
Rotatable Bond Count25
Exact Mass938.26033 g/mol
Monoisotopic Mass938.26033 g/mol
Topological Polar Surface Area431 Ų
Heavy Atom Count54
Formal Charge0
Complexity631
Isotope Atom Count0
Defined Atom Stereocenter Count8
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count4
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameMagnevist
PubMed HealthGadopentetate (Injection)
Drug ClassesRadiological Non-Ionic Contrast Media
Drug LabelMagnevist (brand of gadopentetate dimeglumine) injection is the N-methylglucamine salt of the gadolinium complex of diethylenetriamine pentaacetic acid, and is an injectable contrast medium for magnetic resonance imaging (MRI). Magnevist Injection...
Active IngredientGadopentetate dimeglumine
Dosage FormInjectable
RouteInjection
Strength469.01mg/ml
Market StatusPrescription
CompanyBayer Hlthcare

2 of 2  
Drug NameMagnevist
PubMed HealthGadopentetate (Injection)
Drug ClassesRadiological Non-Ionic Contrast Media
Drug LabelMagnevist (brand of gadopentetate dimeglumine) injection is the N-methylglucamine salt of the gadolinium complex of diethylenetriamine pentaacetic acid, and is an injectable contrast medium for magnetic resonance imaging (MRI). Magnevist Injection...
Active IngredientGadopentetate dimeglumine
Dosage FormInjectable
RouteInjection
Strength469.01mg/ml
Market StatusPrescription
CompanyBayer Hlthcare

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Contrast Media

Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)


DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - INJECTABLE;INJECTION - 469.01MG/ML

USFDA APPLICATION NUMBER - 19596

read-more

DOSAGE - INJECTABLE;INJECTION - 469.01MG/ML

USFDA APPLICATION NUMBER - 21037

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty